Logo image of 1AMGN.MI

AMGEN INC (1AMGN.MI) Stock Price, Quote, News and Overview

BIT:1AMGN - Euronext Milan - US0311621009 - Common Stock - Currency: EUR

299.6  +24.1 (+8.75%)

1AMGN.MI Quote, Performance and Key Statistics

AMGEN INC

BIT:1AMGN (3/4/2025, 7:00:00 PM)

299.6

+24.1 (+8.75%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap160.89B
Shares537.00M
Float535.59M
Yearly Dividend8.52
Dividend Yield3.21%
PE15.84
Fwd PE14.92
Earnings (Next)04-30 2025-04-30/bmo
IPO06-17 1983-06-17


1AMGN.MI short term performance overview.The bars show the price performance of 1AMGN.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6 -8

1AMGN.MI long term performance overview.The bars show the price performance of 1AMGN.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1AMGN.MI is 299.6 EUR. In the past month the price decreased by -4.18%.

AMGEN INC / 1AMGN Daily stock chart

1AMGN.MI Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 21.07 346.68B
1ABBV.MI ABBVIE INC 20.82 342.48B
AMG.DE AMGEN INC 16.43 161.21B
1GILD.MI GILEAD SCIENCES INC 25.67 135.84B
GIS.DE GILEAD SCIENCES INC 25.39 134.40B
VX1.DE VERTEX PHARMACEUTICALS INC 1667.04 115.58B
ARGX.BR ARGENX SE 253.61 33.75B
22UA.DE BIONTECH SE-ADR N/A 24.36B
IDP.DE BIOGEN INC 9.25 20.54B
1BIIB.MI BIOGEN INC 8.39 19.21B
0QF.DE MODERNA INC N/A 13.19B
1MRNA.MI MODERNA INC N/A 12.34B

About 1AMGN.MI

Company Profile

1AMGN logo image Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company is headquartered in Thousand Oaks, California and currently employs 26,700 full-time employees. The firm discovers, develops, manufactures and delivers various human therapeutics. The company focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. The company operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

Company Info

AMGEN INC

One Amgen Center Drive

Thousand Oaks CALIFORNIA US

Employees: 26700

Company Website: https://www.amgen.com/

Investor Relations: https://investors.amgen.com

Phone: 18054471000

AMGEN INC / 1AMGN.MI FAQ

What is the stock price of AMGEN INC today?

The current stock price of 1AMGN.MI is 299.6 EUR. The price increased by 8.75% in the last trading session.


What is the ticker symbol for AMGEN INC stock?

The exchange symbol of AMGEN INC is 1AMGN and it is listed on the Euronext Milan exchange.


On which exchange is 1AMGN.MI stock listed?

1AMGN.MI stock is listed on the Euronext Milan exchange.


What is the price forecast or stock price prediction for AMGEN INC stock?

39 analysts have analysed 1AMGN.MI and the average price target is 306.24 EUR. This implies a price increase of 2.21% is expected in the next year compared to the current price of 299.6. Check the AMGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AMGEN INC worth?

AMGEN INC (1AMGN.MI) has a market capitalization of 160.89B EUR. This makes 1AMGN.MI a Large Cap stock.


How many employees does AMGEN INC have?

AMGEN INC (1AMGN.MI) currently has 26700 employees.


What are the support and resistance levels for AMGEN INC (1AMGN.MI) stock?

AMGEN INC (1AMGN.MI) has a support level at 254.59 and a resistance level at 311.76. Check the full technical report for a detailed analysis of 1AMGN.MI support and resistance levels.


Is AMGEN INC (1AMGN.MI) expected to grow?

The Revenue of AMGEN INC (1AMGN.MI) is expected to grow by 4.04% in the next year. Check the estimates tab for more information on the 1AMGN.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy AMGEN INC (1AMGN.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AMGEN INC (1AMGN.MI) stock pay dividends?

AMGEN INC (1AMGN.MI) has a dividend yield of 3.21%. The yearly dividend amount is currently 8.52. Check the full fundamental report for a detailed analysis of 1AMGN.MI dividend history, reliability and sustainability.


When does AMGEN INC (1AMGN.MI) report earnings?

AMGEN INC (1AMGN.MI) will report earnings on 2025-04-30, before the market open.


What is the Price/Earnings (PE) ratio of AMGEN INC (1AMGN.MI)?

The PE ratio for AMGEN INC (1AMGN.MI) is 15.84. This is based on the reported non-GAAP earnings per share of 18.92 and the current share price of 299.6 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1AMGN.MI.


1AMGN.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 1AMGN.MI.


Chartmill TA Rating
Chartmill Setup Rating

1AMGN.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI. 1AMGN.MI has an excellent profitability rating, but there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1AMGN.MI Financial Highlights

Over the last trailing twelve months 1AMGN.MI reported a non-GAAP Earnings per Share(EPS) of 18.92. The EPS increased by 6.27% compared to the year before.


Industry RankSector Rank
PM (TTM) 13%
ROA 4.65%
ROE 56.2%
Debt/Equity 7.55
Chartmill High Growth Momentum
EPS Q2Q%12.74%
Sales Q2Q%10.86%
EPS 1Y (TTM)6.27%
Revenue 1Y (TTM)18.57%

1AMGN.MI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 73% to 1AMGN.MI. The Buy consensus is the average rating of analysts ratings from 39 analysts.

For the next year, analysts expect an EPS growth of 6.18% and a revenue growth 4.04% for 1AMGN.MI


Ownership
Inst Owners80.93%
Ins Owners0.07%
Short Float %N/A
Short RatioN/A
Analysts
Analysts73.33
Price Target306.24 (2.22%)
EPS Next Y6.18%
Revenue Next Year4.04%